Table Of ContentEuropean  Journal  of Obstetrics  & Gynecology 
ELSEVIER 
and  Reproductive  Biology  71  (1997)  233-234 
Author  index 
Volume  71  (1997) 
Achiron,  R., see  Lipitz,  S.  71, 21  Didenko,  L.V.,  see  Obolenskaya,  M.Y.  71, 23 
Anceschi,  M.M.,  see  Cosmi,  E.V.  71,  135  Dreyfus,  M.,  F. Becmeur,  C. Schwaab,  J.-J.  Baldauf,  L. Philippe,  J. 
Argilés,  J.M.,  see  Carb6,  N.  71, 85  Ritter,  The  pregnant  ewe:  an  animal  model  for  fetoscopic 
Austgulen,  R., E. Lien, G. Vince, C.W.G.  Redman,  Increased  mater-  surgery  71, 91 
nal plasma levels of soluble  adhesion  molecules  (ICAM-1,  VCAM- 
1, E-selectin)  in preeclampsia  71, 53  Ediz,  B., see  Ozan,  H.  71, 35 
Ekblom,  A.O.A.,  see  Olofsson,  C.1.J.  71,  31 
Babic,  D., see  Kurjak,  A.  71,  147  Ekman-Ordeberg,  G.E.,  see  Olofsson,  C.I.J.  71, 31 
Bacsko,  G.,  Uterine  surgery  by operative  hysteroscopy  71, 219  Engelen,  M.J.A.,  see  van  der Stege, J.G.  71, 99 
Baldauf,  J.-J.,  see  Dreyfus,  M.  71, 91  Eskes,  T.K.A.B.,  Folates  and  the fetus  71,  105 
Balogh,  A.,  P.  Bettembuk,  Hormone  replacement  therapy  and  pre-  Eskes,  T.,  Minutes  of  the  General  Assembly:  Budapest,  Hun- 
vention  of osteoporosis:  risk  assessment  and  practical  advice  71,  gary  71, 229 
189  Esmer,  A., see  Ozan,  H.  71,  35 
Barentsen,  R.,  P.H.M.  van  de  Weijer,  J.H.N.  Schram,  Continuous 
low  dose  estradiol  released  from  a  vaginal  ring  versus  estriol  Fleming,  J.E.E.,  see  Smith,  G.C.S.  71, 95 
vaginal  cream  for urogenital  atrophy  71, 73 
Becmeur,  F., see  Dreyfus,  M.  71, 91  Geraedts,  M., see  Selbmann,  H.-K.  71, 223 
Bettembuk,  P., see  Balogh,  A.  71,  189  Goffinet,  F., J. Paris,  N. Heim,  I. Nisand,  G. Breart,  Predictive  value 
Bianco,  D., see  Cosmi,  E.V.  71,  135  of Doppler  umbilical  artery  velocimetry  in a  low  risk  population 
Blondon,  J., see  Verspyck,  E.  71, 81  with  normal  fetal  biometry.  A _ prospective  study  of  2016 
Body,  G., see  Descamps,  P.  71, 3  women  7],  11 
Bozoki,  Z., Chaos  theory and power  spectrum  analysis  in computer-  Gold,  F., see  Descamps,  P.  71, 3 
ized cardiotocography  71,  163  Guichet,  A., see  Descamps,  P.  71, 3 
Breart,  G., see  Goffinet,  F.  71,  11  Guyard,  B., see  Verspyck,  E.  71, 81 
Burger,  C.W.,  see  Kenemans,  P.  71,  199 
Haas,  J., see  Pickel,  H.  71, 209 
Carbo,  N.,  F.J.  Lopez-Soriano,  J.M.  Argilés,  Neutral  amino  acid  Heim,  N., see  Goffinet,  F.  71,  11 
transport  in placental  plasma  membrane  vesicles  in the late  preg-  Herczeg,  J., High-risk  obstetrics,  medicolegal  problems  71,  181 
nant  rat:  Evidence  for a B°-like  transport  system  71, 85  Horoshovski,  D., see  Lipitz,  S.  71, 21 
Castiel,  M., see  Descamps,  P.  71, 3 
Caufriez,  A., The  pubertal  spurt:  effects  of sex  steroids  on  growth  Irestedt,  L.E.,  see  Olofsson,  C.1.J.  71,  31 
hormone  and insulin-like  growth  factor  |  71, 215 
Colenbrander,  G.J.,  see  Mantel,  R.  71, 41  Jakab,  A., Jr.,  Management  of the  menopause  and  HRT  by ultra- 
Copur,  ©.U., see  Ozan,  H.  71, 35  sound  71,  155 
Cosmi,  E.V.,  R.  La  Torre,  J.J.  Piazze,  L.  Maranghi,  N.  Lerro,  D.  Jourdain,  O., see  Descamps,  P.  71, 3 
Bianco,  M.M.  Anceschi,  Intramniotic  surfactant  for prevention  of  Jukic,  S., see  Kurjak,  A.  71,  147 
neonatal  respiratory  distress  syndrome  (IRDS):  rationale  and  per- 
sonal  experience  71,  135  Kenemans,  P., F. Scheele,  C.W.  Burger,  Hormone  replacement  ther- 
Czeglédy,  J., see  Poka,  R.  71,  169  apy  and  breast  cancer  morbidity,  mortality  and  recurrence  71, 
199 
Darves-Bornoz,  J.-M., Rape-related psychotraumatic syndromes  71,  Kenemans,  P., State  of the art  of practical  HRT:  Risks  and benefits 
59  of long-term  HRT:  a calculated  risk?  71,  187 
Decker,  K., see  Obolenskaya,  M.Y.  71, 23  Kolsal,  N., see  Ozan,  H.  71, 35 
Descamps,  P., O. Jourdain,  C.  Paillet,  A.  Toutain,  A.  Guichet,  D.  Kostense,  P.J.,  see  Mantel,  R.  71, 41 
Pourcelot,  F. Gold,  M. Castiel,  G.  Body,  Etiology,  prognosis  and  Kovacs,  L.,  Let  us  build  a  bridge  in  Europe:  Congress  President’s 
management  of nuchal  cystic hygroma:  : 25 new  cases  and  litera-  address  71,  103 
ture  review  71, 3  Kuhn,  W., see  Meden,  H.  71,  173 
Dgani,  R., see  Zalel,  Y.  71, 67  Kupesic,  S.,  A.  Kurjak,  The  assessment  of  uterine  and  ovarian 
Diczfalusy,  E., In search  of human  dignity:  reproductive  health  and  perfusion  in infertile  patients  71,  151 
healthy  aging  71,  123  Kupesic,  S., see  Kurjak,  A.  71,  147
234  Author  index  vol.  71 (1997) 
Kurjak,  A., see  Kupesic,  S.  71,  151  Pickel,  H.,  J.  Haas,  M.  Lahousen,  Prognostic  factors  in  cervical 
Kurjak, A., S. Jukic, S. Kupesic,  D. Babic,  A combined  Doppler and  cancer  71, 209 
morphopathological  study of ovarian  tumors  71,  147  Pines,  A.,  V.  Mijatovic,  M.J.  van  der  Mooren,  Peter  Kenemans, 
Hormone  replacement  therapy  and  cardioprotection:  basic  con- 
Lahousen,  M., see  Pickel,  H.  71, 209  cepts  and clinical  considerations  71,  193 
La Torre,  R., see  Cosmi,  E.V.  71,  135  Poka,  R.,  J.  Czeglédy,  HPV-  and  node  status  in  cervical  cancer: 
Lebedeva,  L.M.,  see  Obolenskaya,  M.Y.  71, 23  Long-term  results  71,  169 
Lefranc,  J.P.,  see  Verspyck,  E.  71, 81  Pourcelot,  D., see  Descamps,  P.  71, 3 
Lerro,  N., see  Cosmi,  E.V.  71,  135 
Lien,  E., see  Austgulen,  R.  71, 53  Redman,  C.W.G.,  see  Austgulen,  R.  71,  53 
Lipitz,  S., R. Achiron,  D. Horoshovski,  Z. Rotstein,  D. Sherman,  E.  Ritter,  J., see  Dreyfus,  M.  71, 91 
Schiff,  Fetomaternal  haemorrhage  discovered  after  trauma  and  Rotstein,  Z., see  Lipitz,  S.  71, 21 
treated  by fetal  intravascular  transfusion  71, 21 
Lopez-Soriano,  F.J.,  see  Carbé,  N.  71, 85  Scheele,  F., see  Kenemans,  P.  71,  199 
Schenker,  J.G.,  Infertility  evaluation  and  treatment  according  to 
Macewicz,  L.L.,  see  Obolenskaya,  M.Y.  71, 23  Jewish  law  71,  113 
Mantel,  R., H.P.  Van  Geijn,  1.A.P.  Ververs,  G.J.  Colenbrander,  P.J.  Schiff,  E., see  Lipitz,  S.  71, 21 
Kostense,  Automated  analysis  of antepartum  fetal  heart  rate  in  Schram,  J.H.N.,  see  Barentsen,  R.  71,  73 
relation  to fetal  rest-activity  states:  A longitudinal  study of uncom-  Schwaab,  C., see  Dreyfus,  M.  71, 91 
plicated  : pregnancies  using the Sonicaid  System  8000  71, 41  Selbmann,  H.-K.,  M.  Geraedts,  Internal  and  external  measures  of 
Maranghi,  L., see  Cosmi,  E.V.  71,  135  quality  assurance  in gynecological  surgery  71, 223 
Meden,  H.,  W.  Kuhn,  Overexpression  of  the  oncogene  c-erbB-2  Sherman,  D., see  Lipitz,  S.  71, 21 
(HER2/neu)  in ovarian  cancer:  a new  prognostic  factor  71,  173  Smith,  G.C.S.,  J.E.E.  Fleming,  Prolonged  fetal  pre-ejection  period 
Mijatovic,  V., see  Pines,  A.  71,  193  corrected  for PR  interval  associated  with  cerebral  palsy  71, 95 
Nisand,  I., see  Goffinet,  F.  71,  11  Toutain,  A., see  Descamps,  P.  71, 3 
Novak-Antolié,  Z., M.  Pajntar,  I. Verdenik,  Rupture  of the  mem-  Tschaikovskaya,  T.L.,  see  Obolenskaya,  M.Y.  71, 23 
branes  and  postpartum  infection  71,  141 
van  der Mooren,  M.J.,  see  Pines,  A.  71,  193 
Obolenskaya,  M.Y.,  T.L.  Tschaikovskaya,  L.M.  Lebedeva,  L.L.  van  der  Stege,  J.G.,  M.J.A.  Engelen,  J.  van  Eyck,  Uncomplicated 
Macewicz,  L.V.  Didenko,  K. Decker,  Glutathione  status  of placen-  pregnancy  and  puerperium  after  puerperal  cerebral  venous  throm- 
tae  from  differently  polluted  regions  of Ukraine  71, 23  bosis  71, 99 
Oddens,  B.J.,  Determinants  of contraceptive  use:  from  birth  control  van  de Weijer,  P.H.M.,  see  Barentsen,  R.  71,  73 
to fertility  awareness  7],  |  van  Eyck,  J., see  van  der Stege,  J.G.  71, 99 
Olofsson,  C.I.J.,  AO.A.  Ekblom,  G.E.  Ekman-Ordeberg,  L.E.  Irest-  Van  Geijn,  H.P.,  see  Mantel,  R.  71, 41 
edt,  Post-partum  urinary  retention:  a  comparison  between  two  Verdenik,  I., see  Novak-Antoli¢,  Z.  71,  141 
methods  of epidural  analgesia  71, 31  Verspyck,  E.,  J.P.  Lefranc,  B.  Guyard,  J.  Blondon,  Treatment  of 
Ozan,  H.,  A.  Esmer,  N.  Kolsal,  O.U.  Copur,  B.  Ediz,  Plasma  bowel endometriosis:  a report of six cases  of colorectal  endometrio- 
ascorbic  acid  level  and  erythrocyte  fragility  in preeclampsia  and  sis and  a survey  of the literature  71, 81 
eclampsia  71, 35  Ververs,  I.A.P.,  see  Mantel,  R.  71, 41 
Vince,  G., see  Austgulen,  R.  71, 53 
Paillet,  C., see  Descamps,  P.  71, 3  von  Schoultz,  B., HRT  and  breast  cancer  risk,  what  to advise?  71, 
Pajntar,  M., see  Novak-Antoli¢,  Z.  71,  141  205 
Paris,  J., see  Goffinet,  F.  71,  11 
Peter  Kenemans,  see  Pines,  A.  71,  193  Zalel,  Y.,  R.  Dgani,  Gestational  trophoblastic  disease  following  the 
Philippe,  L., see  Dreyfus,  M.  71, 91  evacuation  of partial  hydatidiform  mole:  a review  of 66 cases  71, 
Piazze,  J.J., see  Cosmi,  E.V.  71,  135  67
European  Journal  of Obstetrics  & Gynecology 
and  Reproductive  Biology  71  (1997)  235-236 
Subject  index 
Volume  71  (1997) 
Amino  acid  71, 85  Fetomaternal  haemorrhage  71, 21 
Aminophylline  71,  135  Fetoscopy  71, 91 
Animal  model  71, 91  Fetus  71,  105 
Antenatal  treatment  71, 91  Folates  71,  105 
Artificial  insemination  71,  113 
Ascorbic  acid  71, 35  Giant  sections  71, 209 
Automated  analysis  71, 41  Glutathione  reductase  71, 23 
Glutathione  S-transferase  71, 23 
Benchmarking  71, 223  Growth  hormone  71, 215 
Biometry  71, 209  Gynecological  surgery  71, 223 
Bone  densitometry  71,  189 
Borderline  disorder  71,  59  HER2/neu  71,  173 
Bowel  endometriosis  71, 81  High-risk  71,  181 
Breast  cancer  71, 205  High risk  factors  71, 67 
Breast  cancer  morbidity  71,  199  Homocysteine  71,  105 
Bupivacaine  71, 31  Hormone  replacement  71,  155 
;  Hormone  replacement  therapy  71,  193,  199 
Cardiotocography  71,  163  HRT  71.  205 
Cardiovascular disease  71,  193  Human  papillomavirus  71,  169 
Catecholamines  71, 95 
Hysteroscopy  71, 219 
c-erbB-2  71,  173 
Cerebral  palsy  71, 95  .  ICAM-1  71.  53 
Cerebral  venous  thrombosis  71, 99 
Incest  71,  59 
Cervical  cancer  71,  169,  209  é,  ‘ 
Infertile  patients  71,  151 
Cases  Guay.  78,  560  Infertility  71,  113 
Chemical  pollution  71, 23  y  aia 
Insulin-like  growth  factor  I  71, 215 
Climacteric  complaints  71,  199 
Intramniotic  surfactant  71,  135 
Contraception  71,|  
Intrauterine  growth  retardation  71,  11 
Contraceptive  use  71,  | 
Intravascular  fetal  transfusion  71, 21 
IRDS  71,  135 
Determinants  71,|  
Dissociative  disorders  71,  59 
Jewish  law  71,  113 
Doppler  71,  155 
Early diagnosis  71,  189  Karyotype  71, 3 
Eclampsia  71, 35 
Litigation  71,  181 
Endometriosis  71, 81 
Low-risk  pregnancy  71,  11 
Endoscopic  surgery  71, 91 
Lymph-node  71,  169 
Epidural  anesthesia  71, 31 
Erythrocyte  fragility  71, 35 
E-selectin  71, 53  Malonic  dialdehyde  71, 23 
Estradiol  ring  71, 73  Maternal  infection  71,  141 
Estriol  cream  71, 73  Medical  treatment  71, 81 
Estrogen  71,  193  Menopause  71,  155 
Experimental  surgery  71, 91  Methionine  71,  105 
5,10-Methylenetetrahydrofolate-reductase  71,  105 
Fetal  behavioural  states  71, 41 
Fetal  heart  rate  71, 41,  163  Neonatal  infection  71,  141 
Fetal  lung immaturity  71,  135  Neovascularization  71,  147 
Fetal  movements  71, 41  Neural  tube defects  71,  105 
Fetal  rest-activity  states  71, 41  Nuchal  cystic hygroma  71, 3
236  Subject  index  vol.  71 (1997) 
Obstetrics  71,  181  Radical  surgery  71, 209 
Oestrogens  71, 215  Radioactive  contamination  71, 23 
Oncogene  71,  173  Rape  71, 59 
Operative  laparoscopy  71, 81  Regional  osteoporosis  program  71,  189 
Ovarian  and  uterine  lesions  71,  151  Risk  assessment  71,  189 
Ovarian  and  uterine  perfusion  71,  151 
Ovarian  cancer  71,  173  Sinusoidal  spaces  71,  147 
Ovarian  tumors  71,  147  Sufentanil  71, 31 
Surfactant  71,  135 
Partial  mole  71, 67 
Surgical  therapy  71, 81 
Persistent  gestational  trophoblastic  disease  71, 67 
Survival  71,  169,  209 
Placenta  71, 23, 85 
System  8000  71, 41 
Postmenopausal  osteoporosis  71,  189 
Postpartum  71, 31 
Term  prelabour  rupture  of membranes  71,  141 
Post-traumatic  stress  disorder  71, 59 
Testosterone  71, 215 
Power  spectrum  analysis  71,  163 
Thromboprophylaxis  71, 99 
Preeclampsia  71, 35, 53 
Transport  71, 85 
Pre-ejection  period  71, 95 
Transvaginal  color  and  pulsed  Doppler  ultrasound  71,  147 
Pregnancy  71, 35, 53, 99, 219 
Transvaginal  color  Doppler  71,  151 
Preterm  prelabour  rupture  of membranes  71,  141 
Trauma _ 71, 21 
PR  interval  71, 95 
Progestin  71,  193 
Ultrasound  71, 3, 155 
Progestogen  71, 205 
Umbilical  Doppler  velocimetry  71,  11 
Prognosis  71, 3, 173 
Urinary  retention  71, 31 
Prognostic  factors  71, 209 
Urogenital  atrophy  71, 73 
Prospective  study  71,  11 
Uterine  malformation  71, 219 
Pubertal  spurt  71, 215 
Puerperium  71, 99 
Vaginal  mucosa  71], 73 
Quality  assurance  71, 223  VCAM-1_  71, 53 
Quality  management  71, 223  Vessel  morphology  71,  147